Salivary Hormone Testing
Customize your policy alerts
Sign up for mutualofomaha Policy AHS-G2120 alerts
Get alerted when Policy AHS-G2120 changes without checking for updates manually.
Monitor payer policy activity
This policy governs coverage of salivary testing for steroid hormones, including cortisol, estrogen, progesterone, and androgens. It distinguishes covered late-night salivary cortisol testing for individuals with signs and symptoms of Cushing syndrome from excluded screening, diagnostic, and monitoring uses.
The 03/18/2026 revision updated the background, guidelines and recommendations, and evidence-based scientific references.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.